BISULLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 16.567
AS - Asia 15.448
EU - Europa 10.772
SA - Sud America 1.026
AF - Africa 785
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 9
Totale 44.634
Nazione #
US - Stati Uniti d'America 16.223
SG - Singapore 4.085
CN - Cina 3.749
VN - Vietnam 3.734
IT - Italia 2.531
GB - Regno Unito 2.260
DE - Germania 1.461
HK - Hong Kong 1.239
SE - Svezia 1.060
BR - Brasile 749
FR - Francia 697
IN - India 672
RU - Federazione Russa 538
NL - Olanda 501
KR - Corea 421
BD - Bangladesh 413
UA - Ucraina 398
IE - Irlanda 362
JP - Giappone 284
ZA - Sudafrica 229
FI - Finlandia 221
CA - Canada 217
CI - Costa d'Avorio 207
EE - Estonia 136
TG - Togo 120
AR - Argentina 117
JO - Giordania 115
ID - Indonesia 98
PH - Filippine 96
TR - Turchia 93
BG - Bulgaria 88
AT - Austria 87
MX - Messico 81
CH - Svizzera 78
IQ - Iraq 73
TH - Thailandia 69
SC - Seychelles 65
ES - Italia 64
PL - Polonia 55
BE - Belgio 54
UZ - Uzbekistan 49
PK - Pakistan 47
EC - Ecuador 44
GR - Grecia 41
NG - Nigeria 41
TW - Taiwan 40
CO - Colombia 31
SA - Arabia Saudita 30
EG - Egitto 23
CL - Cile 22
LB - Libano 21
AU - Australia 20
MY - Malesia 20
VE - Venezuela 20
LT - Lituania 19
PY - Paraguay 17
TN - Tunisia 17
RO - Romania 16
IR - Iran 15
KE - Kenya 14
PE - Perù 13
DZ - Algeria 12
IL - Israele 12
MA - Marocco 12
PT - Portogallo 11
AL - Albania 10
CZ - Repubblica Ceca 10
HR - Croazia 10
NP - Nepal 10
DK - Danimarca 9
KZ - Kazakistan 9
SK - Slovacchia (Repubblica Slovacca) 9
UY - Uruguay 9
HU - Ungheria 8
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
RS - Serbia 7
PS - Palestinian Territory 6
SN - Senegal 6
LV - Lettonia 5
SI - Slovenia 5
SV - El Salvador 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CG - Congo 4
CM - Camerun 4
GH - Ghana 4
GI - Gibilterra 4
GT - Guatemala 4
HN - Honduras 4
KH - Cambogia 4
LK - Sri Lanka 4
MD - Moldavia 4
NI - Nicaragua 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
OM - Oman 4
TT - Trinidad e Tobago 4
Totale 44.561
Città #
Singapore 2.872
Ashburn 1.916
Southend 1.818
Fairfield 1.462
Hong Kong 1.181
Chandler 1.033
Hefei 902
Ho Chi Minh City 868
San Jose 787
Hanoi 742
Woodbridge 733
Houston 663
Seattle 647
Wilmington 604
Ann Arbor 581
Santa Clara 570
Cambridge 516
Princeton 466
Beijing 464
Bologna 445
Boardman 432
Seoul 389
Dublin 361
Los Angeles 326
Lauterbourg 297
Dallas 277
New York 274
Tokyo 251
Dong Ket 250
Jacksonville 241
Council Bluffs 222
Abidjan 207
Milan 187
Westminster 180
Nanjing 169
Padova 156
Turin 152
Helsinki 146
Berlin 144
Buffalo 140
Frankfurt am Main 122
Lomé 120
Florence 118
Amman 112
Da Nang 112
Haiphong 112
Rome 112
São Paulo 112
Redondo Beach 111
Saint Petersburg 107
Redmond 104
Jinan 100
Munich 99
Bengaluru 90
Sofia 84
San Diego 81
Nuremberg 78
Shenyang 78
Amsterdam 77
Guangzhou 74
London 74
Shanghai 72
Montréal 67
Chicago 65
Changsha 62
Nanchang 56
Falls Church 54
Mülheim 54
Tianjin 54
Jakarta 53
Modena 52
Lappeenranta 51
Vienna 51
Hebei 50
Johannesburg 50
Brussels 49
Hải Dương 48
Medford 47
Bern 46
Biên Hòa 46
Mcallen 46
Des Moines 45
Orem 45
Phoenix 45
Yubileyny 42
Thái Nguyên 41
Zhengzhou 41
Dearborn 40
Montreal 39
Naples 39
Can Tho 38
Falkenstein 38
Abeokuta 37
Toronto 37
Warsaw 37
Hangzhou 35
The Dalles 35
Burlington 34
Mexico City 34
Rio de Janeiro 33
Totale 27.956
Nome #
Clinical features and pathophysiology of disorders of arousal in adults: A window into the sleeping brain 478
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 448
Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data 394
The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units 323
Brain functional connectivity in sleep-related hypermotor epilepsy 306
Aura uditiva in pazienti con epilessia uditiva 279
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 275
Clinical features and long term outcome of epilepsy in periventricular nodular heterotopia. Simple compared with plus forms. 261
LGI1 microdeletions are not a frequent cause of partial epilepsy with auditory features (PEAF). 255
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 250
Adult patients with intellectual disability and epilepsy: clinical and genetic study of 114 cases 250
Contribution of ultrarare variants in mTOR pathway genes to sporadic focal epilepsies 245
A seizure response dog: video recording of reacting behaviour during repetitive prolonged seizures. 235
Auditory aura in nocturnal frontal lobe epilepsy: a red flag to suspect an extra-frontal epileptogenic zone 231
Autosomal dominant partial epilepsy with auditory features: A new locus on chromosome 19q13.11-q13.31. 229
Accurate Detection of Hot-Spot MTOR Somatic Mutations in Archival Surgical Specimens of Focal Cortical Dysplasia by Molecular Inversion Probes 229
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy 228
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 226
Profile of neuropsychological impairment in Sleep-related Hypermotor Epilepsy 224
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. 223
Headache in epilepsy: prevalence and clinical features 222
Videopolygraphic and functional MRI study of musicogenic epilepsy. A case report and literature review. 219
Cerebral areas involved in music perception: studying musicogenic epilepsy. 214
Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study. 211
Telephone-induced seizures: a new type of reflex epilepsy. 211
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: Implications for pathophysiology. 210
Association of intronic variants of the KCNAB1 gene with lateral temporal epilepsy. 210
Diagnostic accuracy of a structured interview for nocturnal frontal lobe epilepsy (SINFLE): a proposal for developing diagnostic criteria. 209
GATOR1 complex: the common genetic actor in focal epilepsies 209
Mesial temporal lobe epilepsy (MTLE): prognostic factors 208
Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsy. 208
Definition of the neurological phenotype associated with dup (X) (p11.22-p11.23). 207
Defective lipid signalling caused by mutations in PIK3C2B underlies focal epilepsy 206
PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy 206
Epilepsy with auditory features: Long-term outcome and predictors of terminal remission 206
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 205
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 205
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture 204
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults with Focal Epilepsy A Phase 2b Randomized Clinical Trial 204
Epilepsy with auditory features: Contribution of known genes in 112 patients 203
BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas 202
Polysomnographic features differentiating disorder of arousals from sleep-related hypermotor epilepsy 202
Corrigendum to “Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: Implications for pathophysiology” [Sleep Medicine 13/3 (2012) 252–262] 200
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 199
Fattori prognostici in 170 pazienti con epilessia temporale mesiale 196
Incidence of sudden unexpected death in nocturnal frontal lobe epilepsy: a cohort study. 196
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 196
Enhancing non-invasive pre-surgical evaluation through functional connectivity and graph theory in drug-resistant focal epilepsy 193
Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 193
Response to the letter "New avenues to prevent sudden unexpected death in nocturnal frontal lobe epilepsy: follow the route established by omega-3 polyunsaturated fatty acids". 193
Definition and diagnostic criteria of sleep-related hypermotor epilepsy 192
Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy 190
Parasomnias versus epilepsy: common grounds and a need to change the approach to the problem. 190
Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders 190
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 190
Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study 189
Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology). 189
Prognostic factors in patients with mesial temporal lobe epilepsy 189
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power 189
FDG-PET assessment and metabolic patterns in Lafora disease 189
Neurological Manifestations of Long {COVID}: A Single-Center One-Year Experience 188
Epilepsy with auditory features: A heterogeneous clinico-molecular disease 188
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study 187
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. 186
Ictal vasodepressive syncope in temporal lobe epilepsy 186
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. 185
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 185
Epilepsy in MT-ATP6 - related mils/NARP: correlation of elettroclinical features with heteroplasmy 185
Phenotype variability of GLUT1 deficiency syndrome: Description of a case series with novel SLC2A1 gene mutations 184
Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS/MS 183
AUTOSOMAL DOMINANT EARLY-ONSET CORTICAL MYOCLONUS, PHOTIC - INDUCED MYOCLONUS, AND EPILEPSY IN A LARGE PEDIGREE 183
A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. 183
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease 181
Juvenile absence epilepsy relapsing as recurrent absence status, mimicking transient global amnesia, in an elderly patient 181
Epilepsy With Auditory Features: From Etiology to Treatment 181
Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy 179
Lateralizing value of the auditory aura in partial seizures. 179
Specific motor patterns of arousal disorders in adults: A video-polysomnographic analysis of 184 episodes 179
Syncope provoked by a temporal lobe seizure. A rare video-polygraphic demonstration. 178
Diagnosis of Nocturnal Frontal Lobe Seizures: The Diagnostic Accuracy of Clinical History. 176
Seizures with paroxysmal arousals in sleep-related hypermotor epilepsy (SHE): Dissecting epilepsy from NREM parasomnias 176
Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy. 175
Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late 174
EEG findings in COVID-19 related encephalopathy 174
A case of clinical worsening after stereo-electroencephalographic-guided radiofrequency thermocoagulation in a patient with polymicrogyria 173
Risk of hospitalization and death for COVID-19 in persons with epilepsy over a 20-month period: The EpiLink Bologna cohort, Italy 172
Prevalence of Nocturnal Frontal Lobe Epilepsy in the Adult Population of Bologna and Modena, Emilia-Romagna Region, Italy. 172
Un caso di epilessia parziale ad esordio precoce. 172
Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. 171
Treatment with metformin in twelve patients with Lafora disease 171
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. 170
Ictal characteristics of psychogenic nonepileptic seizures: what we have learned from video/EEG recordings - a literature review. 169
Sleep-related hypermotor epilepsy: Prevalence, impact and management strategies 169
Increased frequency of arousal parasomnias in families with nocturnal frontal lobe epilepsy: a common mechanism? 169
Cortical myoclonic tremor induced by fixation-off sensitivity: An unusual cause of insomnia 168
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. 167
Neuropsychological impairment in patients with early onset nocturnal frontal lobe epilepsy. 166
Tailored surgery for drug-resistant epilepsy due to temporal pole encephalocele and microdysgenesis. 166
Epilepsy in ring chromosome 20 syndrome 166
Prognostic factors and impact of management strategies for status epilepticus: The STEPPER study in the Emilia-Romagna region, Italy 165
Totale 20.695
Categoria #
all - tutte 122.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021802 0 0 0 0 0 0 0 0 0 0 0 802
2021/20224.287 346 126 273 315 391 226 108 308 198 503 856 637
2022/20234.511 522 622 241 529 307 308 149 218 781 171 483 180
2023/20241.603 109 227 119 180 105 289 72 187 44 111 74 86
2024/20256.547 218 919 449 486 835 310 341 217 150 641 453 1.528
2025/202617.862 1.730 1.734 1.562 1.546 1.694 896 1.912 642 3.070 1.478 979 619
Totale 45.652